entertainment -WSS

entertainment

author：fashion 2025-10-02 10:48:39 - browse：858

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： More hospitals are billing patients as online messages surge

WSS

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

A look at other Americans who have crossed into North Korea over the years

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

A public health expert passes on football's full body collisions for youths

Xenotransplantation trials will require adjusting expectations, experts say

hotspot

entertainment

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Anesthesiologist group: stop taking Ozempic before surgery

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Biogen nominates mother of director’s child to replace him on board

The cancer drug shortage isn’t new — and neither are the solutions

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Guidelines to prevent youth baseball injuries need more muscle

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

focus

Biden administration plans revamp of organ transplant system

Mom launches Girl Scout troop for LGBTQ youth in Texas

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Bispecific antibodies are next new thing in cancer immunotherapy

hotspot

focus

knowledge

explore